AMLX
Amylyx Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $3.33B
- Employees
- 136
- Latest publication
- 2026-09-29
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Further, it develops AMX0318, a GLP-1 receptor antagonist for the treatment of post-bariatric hypoglycemia and other rare diseaees. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20242024-06-30 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | -665,000USD | -1,023,000USD | 108,449,000USD |
| Cost Of Revenue | 98,000USD | 108,000USD | 19,855,000USD | 141,000USD | 22,119,000USD | 160,000USD | 7,626,000USD | 9,360,000USD |
| Gross Profit | -98,000USD | -108,000USD | -19,855,000USD | -141,000USD | -22,119,000USD | -665,000USD | -8,649,000USD | 99,089,000USD |
| Research Development | 27,610,000USD | 21,105,000USD | 19,855,000USD | 27,076,000USD | 22,119,000USD | 22,892,000USD | 23,139,000USD | 44,914,000USD |
| Selling General Administrative | 16,169,000USD | 15,392,000USD | 16,172,000USD | 15,640,000USD | 15,684,000USD | 14,397,000USD | 21,647,000USD | 42,741,000USD |
| Total Operating Expenses | 43,779,000USD | 36,497,000USD | 16,172,000USD | 42,716,000USD | 15,684,000USD | 39,989,000USD | 44,786,000USD | 97,155,000USD |
| Operating Income | -43,779,000USD | -36,605,000USD | -36,027,000USD | -42,857,000USD | -37,803,000USD | -40,654,000USD | -53,435,000USD | 1,934,000USD |
| Interest Income | 2,570,000USD | 3,290,000USD | 1,821,000USD | 1,960,000USD | 2,231,000USD | 2,316,000USD | 4,069,000USD | 4,371,000USD |
| Net Interest Income | 2,570,000USD | 3,290,000USD | 1,821,000USD | 1,960,000USD | 2,231,000USD | 2,316,000USD | 4,069,000USD | 4,371,000USD |
| Income Before Tax | -41,284,000USD | -32,953,000USD | -34,386,000USD | -41,443,000USD | -35,907,000USD | -38,181,000USD | -72,700,000USD | 6,476,000USD |
| Net Income | -41,284,000USD | -32,999,000USD | -34,386,000USD | -41,443,000USD | -35,907,000USD | -37,546,000USD | -72,700,000USD | 4,731,000USD |
| Net Income From Continuing Ops | -41,284,000USD | -32,999,000USD | -34,386,000USD | -41,443,000USD | -35,907,000USD | -37,546,000USD | -72,700,000USD | 4,731,000USD |
| Ebit | -41,284,000USD | -31,057,000USD | -34,386,000USD | -41,443,000USD | -35,907,000USD | -38,181,000USD | -72,700,000USD | 6,476,000USD |
| Ebitda | -41,186,000USD | -30,949,000USD | -34,266,000USD | -41,302,000USD | -35,751,000USD | -38,021,000USD | -72,492,000USD | 6,777,000USD |
| Depreciation And Amortization | 98,000USD | 108,000USD | 120,000USD | 141,000USD | 156,000USD | 160,000USD | 208,000USD | 301,000USD |
| Reconciled Depreciation | 98,000USD | 108,000USD | 120,000USD | 141,000USD | 156,000USD | 160,000USD | 208,000USD | 301,000USD |
| Total Other Income Expense Net | 2,495,000USD | 3,651,000USD | 1,641,000USD | 1,414,000USD | 1,896,000USD | 2,473,000USD | -19,265,000USD | 4,542,000USD |
| Income Tax Expense | — | 46,000USD | — | — | — | -635,000USD | — | 1,745,000USD |
| Tax Provision | — | 46,000USD | 0USD | 0USD | 0USD | -635,000USD | 0USD | 1,745,000USD |
| Unclassified Operating Expenses | — | — | -19,855,000USD | — | -22,119,000USD | — | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | 2,700,000USD | — | 9,500,000USD |
| Interest Expense | — | — | — | — | — | — | — | 3,456,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 0USD | 380,786,000USD | 285,000USD | 1,426,000USD |
| Cost Of Revenue | 525,000USD | 25,441,000USD | 52,000USD | 11,899,000USD |
| Gross Profit | -525,000USD | 355,345,000USD | 285,000USD | -10,473,000USD |
| Research Development | 90,404,000USD | 128,187,000USD | 44,040,000USD | 11,899,000USD |
| Selling General Administrative | 62,887,000USD | 178,856,000USD | 38,933,000USD | 3,081,000USD |
| Total Operating Expenses | 152,766,000USD | 316,543,000USD | 82,688,000USD | 13,554,000USD |
| Operating Income | -153,291,000USD | 38,802,000USD | -82,688,000USD | -13,554,000USD |
| Interest Income | 9,302,000USD | 16,155,000USD | 36,000USD | 176,000USD |
| Net Interest Income | 9,302,000USD | 16,155,000USD | 36,000USD | -1,100,000USD |
| Income Before Tax | -144,689,000USD | 54,297,000USD | -87,931,000USD | -13,716,000USD |
| Income Tax Expense | 46,000USD | 5,026,000USD | -52,000USD | 1,100,000USD |
| Tax Provision | 46,000USD | 5,026,000USD | 0USD | — |
| Net Income | -144,735,000USD | 49,271,000USD | -87,879,000USD | -14,816,000USD |
| Net Income From Continuing Ops | -144,735,000USD | 49,271,000USD | -87,931,000USD | -13,716,000USD |
| Ebit | -144,689,000USD | 54,297,000USD | -82,688,000USD | -12,440,000USD |
| Ebitda | -144,164,000USD | 55,385,000USD | -82,636,000USD | 1,114,000USD |
| Depreciation And Amortization | 525,000USD | 1,088,000USD | 52,000USD | 13,554,000USD |
| Reconciled Depreciation | 525,000USD | 1,088,000USD | 52,000USD | 0USD |
| Total Other Income Expense Net | 8,602,000USD | 15,495,000USD | -5,243,000USD | -162,000USD |
| Selling And Marketing Expenses | — | 9,500,000USD | — | — |
| Interest Expense | — | — | 36,000USD | 1,276,000USD |
| Net Income Applicable To Common Shares | — | — | -87,931,000USD | -13,716,000USD |
| Unclassified Operating Expenses | — | — | — | -1,426,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 264,564,000USD | 293,603,000USD | 332,645,000USD | 362,741,000USD | 194,598,000USD | 219,676,000USD | 193,634,000USD | 250,713,000USD |
| Cash And Equivalents | 49,326,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 250,760,000USD | 279,768,000USD | 316,979,000USD | 343,990,000USD | 180,826,000USD | 204,068,000USD | 176,501,000USD | 234,395,000USD |
| Short Term Investments | 201,434,000USD | 50,632,000USD | 90,328,000USD | 118,812,000USD | 122,741,000USD | 144,304,000USD | 99,110,000USD | 162,556,000USD |
| Total Current Assets | 256,338,000USD | 285,024,000USD | 323,671,000USD | 353,383,000USD | 186,890,000USD | 216,144,000USD | 189,432,000USD | 245,263,000USD |
| Other Current Assets | 5,578,000USD | 5,156,000USD | 6,604,000USD | 9,161,000USD | 5,861,000USD | 11,776,000USD | 12,484,000USD | 9,137,000USD |
| Total Liabilities | 25,397,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 21,150,000USD | 15,966,000USD | 22,688,000USD | 25,791,000USD | 21,424,000USD | 17,932,000USD | 28,406,000USD | 53,915,000USD |
| Other Current Liabilities | 14,609,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 239,167,000USD | 273,161,000USD | 305,259,000USD | 331,996,000USD | 167,877,000USD | 201,417,000USD | 164,765,000USD | 196,203,000USD |
| Total Equity Including Noncontrolling Interest | 239,167,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 4,740,000USD | 5,093,000USD | 5,491,000USD | 5,875,000USD | 6,257,000USD | 2,072,000USD | 2,732,000USD | 3,527,000USD |
| Accounts Payable | 5,533,000USD | 3,529,000USD | 3,519,000USD | 5,339,000USD | 3,294,000USD | 4,810,000USD | 2,939,000USD | 1,487,000USD |
| Short Term Debt | 1,008,000USD | 1,155,000USD | 1,259,000USD | 981,000USD | 665,000USD | 1,055,000USD | 1,518,000USD | 1,972,000USD |
| Common Stock | 11,000USD | 11,000USD | 11,000USD | 11,000USD | 9,000USD | 9,000USD | 7,000USD | 7,000USD |
| Retained Earnings | -836,134,000USD | -792,711,000USD | -751,427,000USD | -718,428,000USD | -684,042,000USD | -642,599,000USD | -606,692,000USD | -569,146,000USD |
| Accumulated Other Comprehensive Income | 19,000USD | 240,000USD | 404,000USD | 815,000USD | 551,000USD | 0USD | -92,000USD | 641,000USD |
| Total Liab | — | 20,442,000USD | 27,386,000USD | 30,745,000USD | 26,721,000USD | 18,259,000USD | 28,869,000USD | 54,510,000USD |
| Other Current Liab | — | 11,282,000USD | 17,910,000USD | 19,471,000USD | 17,465,000USD | 12,067,000USD | 23,949,000USD | 50,456,000USD |
| Capital Stock | — | 11,000USD | 11,000USD | 11,000USD | 9,000USD | 9,000USD | 7,000USD | 7,000USD |
| Cash | — | 229,136,000USD | 226,651,000USD | 225,178,000USD | 58,085,000USD | 59,764,000USD | 77,391,000USD | 71,839,000USD |
| Net Debt | — | -223,505,000USD | -220,694,000USD | -219,243,000USD | -52,123,000USD | -58,382,000USD | -75,410,000USD | -69,272,000USD |
| Short Long Term Debt Total | — | 5,631,000USD | 5,957,000USD | 5,935,000USD | 5,962,000USD | 1,382,000USD | 1,981,000USD | 2,567,000USD |
| Net Receivables | — | 100,000USD | 88,000USD | 232,000USD | 203,000USD | 300,000USD | 447,000USD | 1,731,000USD |
| Property Plant Equipment Gross | — | 5,093,000USD | 7,045,000USD | 5,875,000USD | 6,257,000USD | 2,072,000USD | 4,091,000USD | 3,527,000USD |
| Common Stock Shares Outstanding | — | 110,563,360shares | 94,565,567shares | 93,332,930shares | 89,138,568shares | 85,697,000shares | 68,593,499shares | 68,091,446shares |
| Non Current Assets Total | — | 8,579,000USD | 8,974,000USD | 9,358,000USD | 7,708,000USD | 3,532,000USD | 4,202,000USD | 5,450,000USD |
| Non Current Liabilities Total | — | 4,476,000USD | 4,698,000USD | 4,954,000USD | 5,297,000USD | 327,000USD | 463,000USD | 595,000USD |
| Non Currrent Assets Other | — | 3,486,000USD | 3,483,000USD | 2,500,000USD | 1,451,000USD | 1,460,000USD | 1,470,000USD | 1,923,000USD |
| Net Working Capital | — | 269,058,000USD | 300,983,000USD | 327,592,000USD | 165,466,000USD | 198,212,000USD | 161,026,000USD | 191,348,000USD |
| Unclassified Non Current Liabilities | — | 4,476,000USD | 4,698,000USD | 4,954,000USD | 5,297,000USD | — | — | — |
| Unclassified Equity | — | 1,065,610,000USD | 1,056,260,000USD | 1,049,587,000USD | 851,350,000USD | 843,998,000USD | 771,535,000USD | 764,694,000USD |
| Inventory | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 332,645,000USD | 193,634,000USD | 517,454,000USD | 391,453,000USD | 105,614,000USD | 14,104,000USD | 3,220,000USD |
| Other Current Assets | 6,604,000USD | 12,484,000USD | 14,931,000USD | 10,113,000USD | 8,833,000USD | 762,000USD | 137,000USD |
| Total Liab | 27,386,000USD | 28,869,000USD | 84,022,000USD | 50,846,000USD | 256,782,000USD | 80,829,000USD | 28,577,000USD |
| Total Stockholder Equity | 305,259,000USD | 164,765,000USD | 433,432,000USD | 340,607,000USD | -151,168,000USD | -66,725,000USD | -25,357,000USD |
| Other Current Liab | 17,910,000USD | 23,949,000USD | 57,724,000USD | 38,312,000USD | 13,024,000USD | 3,713,000USD | 2,334,000USD |
| Common Stock | 11,000USD | 7,000USD | 7,000USD | 7,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 11,000USD | 7,000USD | 7,000USD | 7,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -751,427,000USD | -606,692,000USD | -304,949,000USD | -354,220,000USD | -155,845,000USD | -67,914,000USD | -25,634,000USD |
| Cash | 226,651,000USD | 77,391,000USD | 170,201,000USD | 62,526,000USD | 50,191,000USD | 12,877,000USD | 3,065,000USD |
| Cash And Short Term Investments | 316,979,000USD | 176,501,000USD | 371,362,000USD | 346,945,000USD | 96,118,000USD | 12,877,000USD | 3,065,000USD |
| Total Current Assets | 323,671,000USD | 189,432,000USD | 464,666,000USD | 382,133,000USD | 104,951,000USD | 13,639,000USD | 3,202,000USD |
| Total Current Liabilities | 22,688,000USD | 28,406,000USD | 82,042,000USD | 46,609,000USD | 17,396,000USD | 7,326,000USD | 4,529,000USD |
| Net Debt | -220,694,000USD | -75,410,000USD | -165,964,000USD | -56,249,000USD | -50,191,000USD | -11,452,000USD | 11,866,000USD |
| Short Term Debt | 1,259,000USD | 1,518,000USD | 2,257,000USD | 2,040,000USD | — | — | — |
| Short Long Term Debt Total | 5,957,000USD | 1,981,000USD | 4,237,000USD | 6,277,000USD | — | 1,425,000USD | 14,931,000USD |
| Short Term Investments | 90,328,000USD | 99,110,000USD | 201,161,000USD | 284,419,000USD | 45,927,000USD | 0USD | — |
| Net Receivables | 88,000USD | 447,000USD | 40,050,000USD | 15,306,000USD | 0USD | — | — |
| Accounts Payable | 3,519,000USD | 2,939,000USD | 22,061,000USD | 6,257,000USD | 4,372,000USD | 3,613,000USD | 2,195,000USD |
| Property Plant Equipment Net | 5,491,000USD | 2,732,000USD | 6,411,000USD | 8,135,000USD | 474,000USD | 151,000USD | 0USD |
| Property Plant Equipment Gross | 7,045,000USD | 4,091,000USD | 8,039,000USD | 8,675,000USD | 527,000USD | 152,000USD | — |
| Accumulated Other Comprehensive Income | 404,000USD | -92,000USD | 197,000USD | -86,000USD | 9,000USD | -72,062,000USD | -7,675,000USD |
| Common Stock Shares Outstanding | 94,565,567shares | 68,142,000shares | 69,991,340shares | 66,512,011shares | 57,864,186shares | 56,466,013shares | 56,466,013shares |
| Non Current Assets Total | 8,974,000USD | 4,202,000USD | 52,788,000USD | 9,320,000USD | 663,000USD | 465,000USD | 18,000USD |
| Non Current Liabilities Total | 4,698,000USD | 463,000USD | 1,980,000USD | 4,237,000USD | 239,386,000USD | 73,503,000USD | 24,048,000USD |
| Non Currrent Assets Other | 3,483,000USD | 1,470,000USD | 46,377,000USD | 1,185,000USD | 189,000USD | 125,000USD | 18,000USD |
| Net Working Capital | 300,983,000USD | 161,026,000USD | 382,624,000USD | 335,524,000USD | 87,555,000USD | 6,313,000USD | -1,327,000USD |
| Unclassified Non Current Liabilities | 4,698,000USD | — | 1,980,000USD | — | 239,316,000USD | 72,062,000USD | 7,675,000USD |
| Unclassified Equity | 1,056,260,000USD | 771,535,000USD | 738,170,000USD | 694,899,000USD | 4,666,000USD | 73,249,000USD | 7,950,000USD |
| Inventory | — | 0USD | 38,323,000USD | 9,769,000USD | 0USD | — | — |
| Current Deferred Revenue | — | — | 21,887,000USD | — | — | — | — |
| Unclassified Current Liabilities | — | — | -21,887,000USD | — | — | — | — |
| Other Assets | — | — | — | 1USD | 1USD | 1USD | 18,000USD |
| Non Current Liabilities Other | — | — | — | 4,237,000USD | 35,000USD | — | — |
| Net Tangible Assets | — | — | — | 340,607,000USD | -151,168,000USD | -66,725,000USD | -25,357,000USD |
| Other Liab | — | — | — | — | 35,000USD | 16,000USD | 1,442,000USD |
| Long Term Debt | — | — | — | — | — | 1,425,000USD | 14,931,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -41,284,000USD | -32,999,000USD | -34,386,000USD | -41,443,000USD | -35,907,000USD | -37,546,000USD | -72,704,000USD | -72,700,000USD |
| Depreciation | 98,000USD | 108,000USD | 120,000USD | 141,000USD | 156,000USD | 160,000USD | 221,000USD | 208,000USD |
| Stock Based Compensation | 6,120,000USD | 6,386,000USD | 7,076,000USD | 7,350,000USD | 6,833,000USD | 6,741,000USD | 6,803,000USD | 9,570,000USD |
| Other Non Cash Items | 3,444,000USD | -1,490,000USD | -1,243,000USD | -1,259,000USD | -1,703,000USD | -1,660,000USD | 34,707,000USD | 5,037,000USD |
| Change In Working Capital | -5,260,000USD | 92,000USD | -1,935,000USD | 9,963,000USD | -9,203,000USD | -26,703,000USD | -10,597,000USD | -8,695,000USD |
| Total Cash From Operating Activities | -36,882,000USD | -27,903,000USD | -30,368,000USD | -25,248,000USD | -39,824,000USD | -59,008,000USD | -41,570,000USD | -66,580,000USD |
| Capital Expenditures | 0USD | -86,000USD | -24,000USD | -17,000USD | -11,000USD | -20,000USD | -19,000USD | -89,000USD |
| Free Cash Flow | -36,882,000USD | -27,989,000USD | -30,392,000USD | -25,265,000USD | -39,835,000USD | -59,028,000USD | -41,551,000USD | -66,669,000USD |
| Investments | 40,262,000USD | 29,554,000USD | 5,236,000USD | 22,994,000USD | -43,659,000USD | 64,980,000USD | 38,816,000USD | -28,961,000USD |
| Total Cashflows From Investing Activities | 36,262,000USD | 29,468,000USD | 5,236,000USD | 22,994,000USD | -43,659,000USD | 64,980,000USD | 38,816,000USD | -28,961,000USD |
| Total Cash From Financing Activities | 3,217,000USD | -208,000USD | 191,606,000USD | -31,000USD | 65,662,000USD | 110,000USD | 80,000USD | 27,000USD |
| Change In Cash | 2,485,000USD | 1,475,000USD | 167,093,000USD | -1,679,000USD | -17,624,000USD | 5,557,000USD | -2,438,000USD | -95,553,000USD |
| Begin Period Cash Flow | 226,651,000USD | 226,161,000USD | 58,085,000USD | 59,764,000USD | 78,837,000USD | 73,280,000USD | 75,718,000USD | 171,271,000USD |
| End Period Cash Flow | 229,136,000USD | 227,636,000USD | 225,178,000USD | 58,085,000USD | 61,213,000USD | 78,837,000USD | 73,280,000USD | 75,718,000USD |
| Other Cashflows From Financing Activities | -3,942,000USD | -256,897,000USD | -2,164,000USD | -103,000USD | 64,692,000USD | 110,000USD | 80,000USD | 27,000USD |
| Unclassified Investing Cash Flow | -4,000,000USD | — | — | — | 43,659,000USD | — | 36,222,000USD | 28,961,000USD |
| Unclassified Financing Cash Flow | 7,159,000USD | 256,689,000USD | 193,770,000USD | — | 1,855,000USD | — | -1,335,000USD | — |
| Change To Account Receivables | — | 50,000USD | -85,000USD | 205,000USD | 213,000USD | 980,000USD | 2,243,000USD | 16,564,000USD |
| Change To Inventory | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Sale Purchase Of Stock | — | — | — | — | -885,000USD | — | 1,335,000USD | -20,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | -43,648,000USD | — | -36,203,000USD | -28,872,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -144,735,000USD | -301,743,000USD | 49,271,000USD | -198,375,000USD | -87,931,000USD | -42,280,000USD |
| Depreciation | 525,000USD | 904,000USD | 1,088,000USD | 487,000USD | 52,000USD | 1,000USD |
| Stock Based Compensation | 27,645,000USD | 33,038,000USD | 37,161,000USD | 21,714,000USD | 3,136,000USD | 243,000USD |
| Other Non Cash Items | -5,695,000USD | 145,985,000USD | -9,940,000USD | -2,056,000USD | 5,349,000USD | 2,740,000USD |
| Change To Account Receivables | 383,000USD | 39,602,000USD | -24,744,000USD | -15,306,000USD | -144,000USD | -15,306,000USD |
| Change To Inventory | 0USD | -9,253,000USD | -73,129,000USD | -9,769,000USD | -9,769,000USD | -9,769,000USD |
| Change In Working Capital | -1,083,000USD | -45,831,000USD | -65,661,000USD | -1,641,000USD | 4,595,000USD | 2,599,000USD |
| Total Cash From Operating Activities | -123,343,000USD | -167,647,000USD | 11,919,000USD | -179,871,000USD | -74,799,000USD | -36,697,000USD |
| Capital Expenditures | -138,000USD | -157,000USD | -1,241,000USD | -2,526,000USD | -353,000USD | -151,000USD |
| Free Cash Flow | -123,481,000USD | -167,804,000USD | 10,678,000USD | -182,397,000USD | -75,152,000USD | -36,848,000USD |
| Investments | 14,177,000USD | 75,654,000USD | -157,052,000USD | -236,462,000USD | -46,406,000USD | -46,053,000USD |
| Total Cashflows From Investing Activities | 14,039,000USD | 75,654,000USD | 92,053,000USD | -238,988,000USD | -46,406,000USD | -151,000USD |
| Total Cash From Financing Activities | 257,029,000USD | 348,000USD | 3,543,000USD | 431,789,000USD | 158,506,000USD | 46,823,000USD |
| Change In Cash | 148,799,000USD | -92,083,000USD | 107,675,000USD | 12,865,000USD | 37,314,000USD | 9,975,000USD |
| Begin Period Cash Flow | 78,837,000USD | 170,920,000USD | 62,526,000USD | 50,380,000USD | 13,066,000USD | 3,091,000USD |
| End Period Cash Flow | 227,636,000USD | 78,837,000USD | 170,201,000USD | 63,245,000USD | 50,380,000USD | 13,066,000USD |
| Other Cashflows From Financing Activities | -3,361,000USD | -1,784,000USD | -3,315,000USD | -658,000USD | 132,610,000USD | 30,006,000USD |
| Unclassified Financing Cash Flow | 260,390,000USD | 2,132,000USD | 10,173,000USD | — | -135,000,000USD | -29,958,000USD |
| Other Cashflows From Investing Activities | — | -36,203,000USD | — | -236,462,000USD | 3,000,000USD | — |
| Unclassified Investing Cash Flow | — | 36,360,000USD | 250,346,000USD | 236,462,000USD | -2,647,000USD | 46,053,000USD |
| Net Borrowings | — | — | 0USD | 0USD | 25,896,000USD | 16,817,000USD |
| Sale Purchase Of Stock | — | — | -3,315,000USD | 434,636,000USD | — | — |
| Issuance Of Capital Stock | — | — | 231,550,000USD | 432,447,000USD | 135,000,000USD | 29,958,000USD |
| Change To Liabilities | — | — | — | 1,854,000USD | 670,000USD | 1,418,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 12,930,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.